Once picked as a $500M winner, bankrupt Achaogen auctions off its antibiotic for a fraction of that

Achaogen has just about wrapped up its going-out-of-business sale, with a small group of buyers from around the globe picking up its main antibiotic assets for a song. And they’re just one short telephone auction away from selling their last remaining clinical program.